Ignite Creation Date:
2024-05-06 @ 2:26 PM
Last Modification Date:
2024-10-26 @ 1:31 PM
Study NCT ID:
NCT04329429
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-12-20
First Post:
2020-03-27
Brief Title:
A Study of RC48-ADC in Subjects With HER2 Overexpressed Metastatic Biliary Tract Cancer
Sponsor:
RemeGen Co Ltd
Organization:
RemeGen Co Ltd
Organization Data
Organization:
RemeGen Co Ltd
Class:
INDUSTRY
Study ID:
RC48-C010
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
RemeGen Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None